Analysis of serum proteome profiles of non-Hodgkin lymphoma for biomarker identification

Journal of Proteomics

Volumn 72, Issue 6, 2009, Pages 952-959

  Zhang, Ming Zhi ^a   Sun, Zhen Chang ^a   Fu, Xiao Rui ^a   Nan, Fei Fei ^a   Fan, Qing Xia ^a   Wu, Xing Ai ^a   Geng, Li ^a   Ma, Wang ^a   Wang, Rui Lin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Differentially expressed proteins; Non Hodgkin lymphoma; SELDI TOF MS

Indexed keywords

BIOLOGICAL MARKER; LACTATE DEHYDROGENASE; PLASMA PROTEIN; PROTEOME;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHADENITIS; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; L-LACTATE DEHYDROGENASE; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; PROGNOSIS; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 67651175870     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.03.009     Document Type: Article

References (21)

1. Zhang M.Z., Li W.C., and Wang R.L. The diagnostics and therapeutics of malignant lymphoma. 1st Edition (2003), The publishing company of Zhengzhou University, ZhengZhou 150-160
2. Zhang MZ, Sun ZC, Wang GL, Wang HL, Xing Z, Wu GY, et al. Detection of IgH rearrangement in B cell lymphoma patients' peripheral blood. J Zhengzhou Univ (Med Sci) 2007;42(2):253-255.
3. Sun ZC, Wang GL, Zhang MZ, Wu GY. The protein chip mass spectra and its application in tumor researching. Cent Plains Med J 2006;33(7):60-61.
4. Abramovitz M., and Leyland-Jones B.R. A systems approach to clinical oncology: focus on breast cancer. Proteome Sci 5 4 (2006) 11-26
5. Hellström M, Lexander H, Franzén B, Egevad L. Proteomics in prostate cancer research. Anal Quant Cytol Histol 2007;29(1):32-40.
6. Engwegen JY, Helgason HH,Cats A, Harris N, Bonfrer JM, Schellens JH, et al. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionization-time of flight mass spectrometry. World J Gastroenterol 2006;12(10):1536.
7. Chen CD, Wang CS, Huang YH, Chien KY, Liang Y, Chen WJ, et al. Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics 2007;7(1):155-67.
8. Kong F, Nicole White C, Xiao X, Feng Y, Xu C, He D, et al. Using proteomic approa-ches to identify new biomarkers for detection and monitoring of ovarian cancer. Gynecol Oncol 2006;100(2):247.
9. Seibert V, Wiesner A, Buschmann T, Meuer J. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research. Pathol Res Pract 2004;200(2):83-94.
10. Breimann L.J., Friedmann R.O., and Sone C. Classification and regression tress. 1st Edition (1984), Chapman&Hall (Wadsworth, Inc.), New York 87-90
11. Caballero MD, Pérez-Simón JA, Iriondo A, Lahuerta JJ, Sierra J, Marín J,et al. High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol 2003;14(1):140-51.
12. Yamaguchi M, Suzuki R, Kwong YL, Kim WS, Hasegawa Y, Izutsu K, et al. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008;99(5):1016-20.
13. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. Cancer J Clin 2000;50(1):34-49.
14. Schipper R, Loof A, de Groot J, Harthoorn L, van Heerde W, Dransfield E. Salivary Protein/Peptide Profiling with SELDI-TOF-MS. Ann N Y Acad Sci 2007;1098(3):498-503.
15. Luo J, Qian JH, Yu JK, Zheng S, Xie X, Lu WG. Discovery of altered protein profiles in epithelial ovarian carcinogenesis by SELDI mass spectrometry. Eur J Gynaecol Oncol 2008;29(3):233-8.
16. Brozkova K, Budinska E, Bouchal P, Hernychova L, Knoflickova D,Valik D, et al. Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression. Breast Cancer Res 2008;10(3):107.
17. Gonçalves A., Charafe-Jauffret E., Bertucci F., Audebert S., Toiron Y., Esterni B., et al. Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes. Mol Cell Proteomics 7 8 (2008) 1420-1433
18. Han K.Q., Huang G., Gao C.F., Wang X.L., Ma B., Sun L.Q., et al. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Am J Clin Oncol 31 2 (2008) 133-139
19. Scholl S., Melle C., Bleul A., Spies-Weisshart B., Kunert C., Höffken K., et al. Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations. Leuk Lymphoma 48 12 (2007) 2418-2423
20. Cervi D, Yip TT, Bhattacharya N, Podust VN, Peterson J, Abou-Slaybi A, et al. Platelet-associated PF-4 as a biomarker of early tumor growth. Blood 2008;111(3):1201-12.
21. Zinkin N.T., Grall F., Bhaskar K., Otu H.H., Spentzos D., Kalmowitz B., et al. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res 14 2 (2008) 470-477